Skip to main content

Advertisement

SpringerLink
Log in

Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome?

  • Materno-fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

We designed this retrospective study to evaluate the association between maternal and fetal parameters and perinatal mortality in hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome.

Methods

In this retrospective study, 152 pregnancies complicated with HELLP syndrome were evaluated. Risk factors recorded were maternal age, gravidity, gestational age (weeks), systolic and diastolic blood pressure, platelet count, alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), fetal weight, and Apgar scores. The association of these factors with perinatal mortality was determined. Statistical analyses were performed using the Chi-square (χ 2) test with Yates’ correction, the Student’s t test, logarithmic transformation, and the logistic regression method.

Results

Ninety-two (60.52%) patients had mild preeclampsia, 46 (22.2%) had eclampsia, and 14 (15.2%) had severe preeclampsia. The fetal mortality rate was higher in eclamptic and severe preeclamptic patients (P = 0.029). No correlation was found between maternal age, laboratory values (platelet count, ALT, AST, and LDH), or systolic and diastolic blood pressure and fetal morbidity. According to the logistic regression model, fetuses with prematurity, low birth weight, and low Apgar scores (Apgar score 1 ≤ 3 and Apgar score 5 ≤ 5) were found to be at significant risk for perinatal mortality (P < 0.001). The odds ratios (95% CI) were 3.0 (2–5), 3.42 (1.82–6.41), 0.62 (0.44–0.86) and 4.66 (2.04–10.63), respectively.

Conclusions

Maternal laboratory and clinical parameters were not associated with fetal mortality. Fetal prematurity, low birth weight, and low Apgar scores were significantly associated with fetal mortality. The HELLP syndrome and severe preeclampsia may be life threatening to the mother; therefore, the accepted treatment is expeditious delivery. Our study indicates that prevention of prematurity must be the main priority for the fetus in pregnancies complicated by the HELLP syndrome. This can be efficaciously achieved using glucocorticoid therapy for lung maturity and ensuring that delivery is at an experienced hospital with a multidisciplinary approach including a neonatal intensive care unit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Prichard JA, Weissman R, Ratnoff OD (1954) Intravascular hemolysis, thrombocytopenia, and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 250:89–98

    Article  Google Scholar 

  2. Weinstein L (1982) Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142:159–167

    PubMed  CAS  Google Scholar 

  3. Sibai B, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785–799

    PubMed  Google Scholar 

  4. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 169:1000–1006

    PubMed  CAS  Google Scholar 

  5. Sibai BM (2004) Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 103:981–991

    Article  PubMed  Google Scholar 

  6. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM (2000) Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. Am J Obstet Gynecol 183:444–448

    Article  PubMed  CAS  Google Scholar 

  7. Tranquilli AL, Giannibulo SR (2004) The weight of fetal growth restriction in 437 hypertensive pregnancies. Arch Gynecol Obstet 270:214–216

    Article  PubMed  Google Scholar 

  8. ACOG Committee on Practice Bulletins—Obstetrics (2002) ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 33(99):159–167

    Article  Google Scholar 

  9. Celik Y (2007) Biostatistics, Principles of research, Dicle University Press

  10. Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N (2007) Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 8:648–651

    Article  Google Scholar 

  11. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr (1999) Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 181:924–928

    Article  PubMed  CAS  Google Scholar 

  12. Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H (2006) Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. Sao Paulo Med J 124:85–88

    Article  PubMed  Google Scholar 

  13. Haram K, Svendsen E, Abildgaard U (2009) The HELLP syndrome: clinical issues and management. Rev BMC Pregnancy Childbirth 26:8–9

    Article  Google Scholar 

  14. Liu CM, Chang SD, Cheng PJ, Chao AS (2006) Comparisons of maternal and perinatal outcomes in Taiwanese women with complete and partial HELLP syndrome and women with severe pre-eclampsia without HELLP. J Obstet Gynaecol Res 32:550–558

    Article  PubMed  CAS  Google Scholar 

  15. Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y (2005) Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 59:113–118

    Article  PubMed  Google Scholar 

  16. Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R (2007) HELLP syndrome—a multisystemic disorder. J Gastrointestin Liver Dis 16:419–424

    PubMed  Google Scholar 

  17. Yücesoy G, Ozkan S, Bodur H, Tan T, Calişkan E, Vural B, Corakçi A (2005) Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 273:43–49

    Article  PubMed  Google Scholar 

  18. Martin JN Jr, Thigpen BD, Rose CH, Cushman J, Moore A, May WL (2003) Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 189:830–834

    Article  PubMed  CAS  Google Scholar 

  19. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM (1999) Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 180:221–225

    Article  PubMed  CAS  Google Scholar 

  20. Kim HY, Sohn YS, Lim JH, Kim EH, Kwon JY, Park YW, Kim YH (2006) Neonatal outcome after preterm delivery in HELLP syndrome. Yonsei Med J 47:393–398

    Article  PubMed  Google Scholar 

  21. van Pampus MG, Wolf H, Westenberg SM, van der Post JA, Bonsel GJ, Treffers PE (1998) Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 76:31–36

    Article  PubMed  Google Scholar 

  22. Osmanağaoğlu MA, Erdoğan I, Zengin U, Bozkaya H (2004) Comparison between HELLP syndrome, chronic hypertension and superimposed preeclampsia on chronic hypertension without HELLP syndrome. J Perinat Med 32:481–485

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We thank textcheck (http://www.textcheck.com/certificate/nOlsRF) for English revision.

Conflict of interest statement

We declare we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey

    Ali Irfan Guzel & Umur Kuyumcuoglu

  2. Department of Biostatistics and Medical Informatics, Faculty of Medicine, Dicle University, Diyarbakir, Turkey

    Yusuf Celik

Authors
  1. Ali Irfan Guzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Umur Kuyumcuoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuf Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Irfan Guzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guzel, A.I., Kuyumcuoglu, U. & Celik, Y. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome?. Arch Gynecol Obstet 283, 1227–1232 (2011). https://doi.org/10.1007/s00404-010-1534-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-010-1534-x

Keywords

Search

Navigation